Citation Impact
Citing Papers
Oxidative Stress
2017 Standout
Fluorinated Alkyl Surfactants
2003
Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression
1996
The Organization, Promoter Analysis, and Expression of the Human PPARγ Gene
1997 Standout
Molecular mediators of hepatic steatosis and liver injury
2004 Standout
Thiazolidinediones
2004 Standout
Mitochondrial Permeability Transition as the Critical Target of N-Acetyl Perfluorooctane Sulfonamide Toxicity in Vitro
2004
Delayed graft function in kidney transplantation
2004 Standout
Restricted feeding uncouples circadian oscillators in peripheral tissues from the central pacemaker in the suprachiasmatic nucleus
2000 Standout
The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
1998 StandoutNature
Mechanisms of Peroxisome Proliferation by Perfluorooctanoic Acid and Endogenous Fatty Acids
1998
Early effects on mitochondrial and peroxisomal β-oxidation by the hypolipidemic 3-thia fatty acids in rat livers
1993
Differential Activation of Nuclear Receptors by Perfluorinated Fatty Acid Analogs and Natural Fatty Acids: A Comparison of Human, Mouse, and Rat Peroxisome Proliferator-Activated Receptor-α, -β, and -γ, Liver X Receptor-β, and Retinoid X Receptor-α
2006
Inhibition of Gap Junctional Intercellular Communication by Perfluorinated Compounds in Rat Liver and Dolphin Kidney Epithelial Cell Lines in Vitro and Sprague-Dawley Rats in Vivo
2002
PPARα Agonist-Induced Rodent Tumors: Modes of Action and Human Relevance
2003
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis
2007 Standout
Anaplerosis of the citric acid cycle: role in energy metabolism of heart and skeletal muscle
2000
Epidemiologic Assessment of Worker Serum Perfluorooctanesulfonate (PFOS) and Perfluorooctanoate (PFOA) Concentrations and Medical Surveillance Examinations
2003
Serum Perfluorooctane Sulfonate and Hepatic and Lipid Clinical Chemistry Tests in Fluorochemical Production Employees
1999
Perfluoroalkyl Acids: A Review of Monitoring and Toxicological Findings
2007 Standout
Expression of the Peroxisome Proliferator-activated Receptor α Gene Is Stimulated by Stress and Follows a Diurnal Rhythm
1996
Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes
2008 Standout
The peroxisome proliferator activated receptors (PPARs) and their effects on lipid metabolism and adipocyte differentiation
1996
Fatty acid import into mitochondria
2000
Rat PPARs: Quantitative Analysis in Adult Rat Tissues and Regulation in Fasting and Refeeding
2001
Gene Expression Profiles in Rat Liver Treated With Perfluorooctanoic Acid (PFOA)
2005
Analysis of Episodes of Care in a Perfluorooctanesulfonyl Fluoride Production Facility
2004
Sites of Superoxide and Hydrogen Peroxide Production by Muscle Mitochondria Assessed ex Vivo under Conditions Mimicking Rest and Exercise
2014
Developmental Toxicity of Perfluorooctanoic Acid in the CD-1 Mouse after Cross-Foster and Restricted Gestational Exposures
2006
Mortality of employees of a perfluorooctanesulphonyl fluoride manufacturing facility
2003
Inflammation, stress, and diabetes
2005 Standout
Transcriptional Regulation of Metabolism
2006
Control of pyruvate dehydrogenase kinase gene expression
2001
Targeted Disruption of the Nuclear Receptor FXR/BAR Impairs Bile Acid and Lipid Homeostasis
2000 Standout
Identification of genes responsive to PFOS using gene expression profiling
2004
Structural Determinants of Fluorochemical-Induced Mitochondrial Dysfunction
2002
PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
1998 StandoutNature
PLASMA CHOLECYSTOKININ AND HEPATIC ENZYMES, CHOLESTEROL AND LIPOPROTEINS IN AMMONIUM PERFLUOROOCTANOATE PRODUCTION WORKERS
2000
The developmental toxicity of perfluoroalkyl acids and their derivatives
2004
Myocardial Substrate Metabolism in the Normal and Failing Heart
2005 Standout
PPAR-α and PPAR-γ activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway
2001
Pyruvate: Metabolic Protector of Cardiac Performance
2000
A PPARγ-LXR-ABCA1 Pathway in Macrophages Is Involved in Cholesterol Efflux and Atherogenesis
2001
trans-Activation of PPAR and Induction of PPAR Target Genes by Perfluorooctane-Based Chemicals
2004
Perfluorooctanoate, perflourooctanesulfonate, and N-ethyl perfluorooctanesulfonamido ethanol; peroxisome proliferation and mitochondrial biogenesis
2002
Subchronic Toxicity Studies on Perfluorooctanesulfonate Potassium Salt in Cynomolgus Monkeys
2002
Exposure to Perfluorooctane Sulfonate during Pregnancy in Rat and Mouse. I: Maternal and Prenatal Evaluations
2003
PPAR-α effects on the heart and other vascular tissues
2003
Regulation of PPAR gamma gene expression by nutrition and obesity in rodents.
1996
Neonatal mortality from in utero exposure to perfluorooctanesulfonate (PFOS) in Sprague–Dawley rats: Dose–response, and biochemical and pharamacokinetic parameters
2005
Mechanisms of fatty acid-induced inhibition of glucose uptake.
1994 Standout
Peroxisome proliferating sulphur- and oxy-substituted fatty acid analogues are activated to acyl coenzyme a thioesters
1991
Toxicity of Ammonium Perfluorooctanoate in Male Cynomolgus Monkeys after Oral Dosing for 6 Months
2002
Evaluation of biochemical effects related to perfluorooctane sulfonic acid exposure in organohalogen-contaminated great tit (Parus major) and blue tit (Parus caeruleus) nestlings
2005
Adipocyte differentiation from the inside out
2006 Standout
Sex differences in immune responses
2016 Standout
Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies
2009 Standout
Perfluorooctane sulfonic acid and organohalogen pollutants in liver of three freshwater fish species in Flanders (Belgium): relationships with biochemical and organismal effects
2005
Activation of alkylthioacrylic acids in subcellular fractions of rat tissues: a new spectrophotometric method for assay of acyl-CoA synthetase
1994
Interactions of flurochemicals with rat liver fatty acid-binding protein
2002
Obesity is associated with macrophage accumulation in adipose tissue
2003 Standout
Atherosclerosis
2001 Standout
Propionyl-l-carnitine prevents renal function deterioration due to ischemia/reperfusion
2002
Sequence of the bovine 2-oxoglutarate/malate carrier protein: structural relationship to other mitochondrial transport proteins
1990 StandoutNobel
Sub-chronic dietary toxicity of potassium perfluorooctanesulfonate in rats
2003
New insights in the pathogenesis of non-alcoholic fatty liver disease
2006
PHD3 Loss in Cancer Enables Metabolic Reliance on Fatty Acid Oxidation via Deactivation of ACC2
2016 StandoutNobel
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
2008 Standout
Roles of PPARs in health and disease
2000 StandoutNature
Adipose Tissue as an Endocrine Organ
2004 Standout
Fatty Acid Synthase Inhibition in Human Breast Cancer Cells Leads to Malonyl-CoA-Induced Inhibition of Fatty Acid Oxidation and Cytotoxicity
2001
The Toxicology of Perfluorooctanoate
2004
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
Identification of Farnesoid X Receptor β as a Novel Mammalian Nuclear Receptor Sensing Lanosterol
2003 StandoutNobel
Molecular Control of Immune/Inflammatory Responses: Interactions Between Nuclear Factor-κB and Steroid Receptor-Signaling Pathways
1999
Autoregulation of the Human Liver X Receptor α Promoter
2001
Nanozymes: Classification, Catalytic Mechanisms, Activity Regulation, and Applications
2019 Standout
Occurrence and persistence of perfluorooctanesulfonate and other perfluorinated surfactants in groundwater at a fire-training area at Wurtsmith Air Force Base, Michigan, USAElectronic supplementary information (ESI) available: Map of location of Wurtsmith Air Force Base, Oscoda, MI and surrounding states. See http://www.rsc.org/suppdata/em/b2/b212497a/
2003
Orphan Nuclear Receptors: From Gene to Function*
1999
Nuclear Receptors and Lipid Physiology: Opening the X-Files
2001 StandoutScience
Myocardial Fatty Acid Metabolism in Health and Disease
2010 Standout
Dietary influences on serum lipids and lipoproteins.
1990
Investigation of potential mechanisms regulating protein expression of hepatic pyruvate dehydrogenase kinase isoforms 2 and 4 by fatty acids and thyroid hormone
2003
Historical Comparison of Perfluorooctanesulfonate, Perfluorooctanoate, and Other Fluorochemicals in Human Blood
2005
Sequence of the bovine mitochondrial phosphate carrier protein: structural relationship to ADP/ATP translocase and the brown fat mitochondria uncoupling protein.
1987 StandoutNobel
Identification of Early Proteomic Markers for Hepatic Steatosis
2006
Adipose Tissue Expression of the Lipid Droplet–Associating Proteins S3-12 and Perilipin Is Controlled by Peroxisome Proliferator–Activated Receptor-γ
2004
PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS: A Nuclear Receptor Signaling Pathway in Lipid Physiology
1996
Abundant bacterial expression and reconstitution of an intrinsic membrane-transport protein from bovine mitochondria
1993 StandoutNobel
Opposite Effects of Androgens and Estrogens on Adipogenesis in Rat Preadipocytes: Evidence for Sex and Site-Related Specificities and Possible Involvement of Insulin-Like Growth Factor 1 Receptor and Peroxisome Proliferator-Activated Receptorγ 21
2000
Alterations by perfluorooctanoic acid of glycerolipid metabolism in rat liver
1999
Acetyl-CoA carboxylase 2 mutant mice are protected against obesity and diabetes induced by high-fat/high-carbohydrate diets
2003
Pleiotropic Actions of Peroxisome Proliferator–Activated Receptors in Lipid Metabolism and Atherosclerosis
2002
Determinants of Fetal Exposure to Polyfluoroalkyl Compounds in Baltimore, Maryland
2007
Brown Adipose Tissue: Function and Physiological Significance
2004 Standout
Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ
1997 Standout
Understanding Adipocyte Differentiation
1998 Standout
Mechanisms of Estrogen Action
2001 Standout
Global Distribution of Perfluorooctane Sulfonate in Wildlife
2001 Standout
Hypoxia-Inducible Factor 1 and Dysregulated c-Myc Cooperatively Induce Vascular Endothelial Growth Factor and Metabolic Switches Hexokinase 2 and Pyruvate Dehydrogenase Kinase 1
2007 StandoutNobel
Pyruvate carboxylation in the rat heart. Role of biotin-dependent enzymes
1989
How Do Glucocorticoids Influence Stress Responses? Integrating Permissive, Suppressive, Stimulatory, and Preparative Actions*
2000 Standout
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
2005 Standout
Biochemical effect evaluation of perfluorooctane sulfonic acid-contaminated wood mice (Apodemus sylvaticus).
2004
The metabolic significance of anion transport in mitochondria
1974
Activated Liver X Receptors Stimulate Adipocyte Differentiation through Induction of Peroxisome Proliferator-Activated Receptor γ Expression
2004
Fatty Acids and Derivatives as Antimicrobial Agents
1972 Standout
Effects of thia-substituted fatty acids on mitochondrial and peroxisomal β-oxidation. Studies in vivo and in vitro
1990
Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ
1997 Standout
NMR structure of the sterol carrier protein-2: implications for the biological role 1 1Edited by P. E. Wright
2000 StandoutNobel
The gut microbiota as an environmental factor that regulates fat storage
2004 Standout
Propionyll -Carnitine Improvement of Hypertrophied Heart Function Is Accompanied by an Increase in Carbohydrate Oxidation
1995
Obesity is associated with macrophage accumulation in adipose tissue
2003 Standout
The Applicability of Biomonitoring Data for Perfluorooctanesulfonate to the Environmental Public Health Continuum
2006
Microarray Analyses during Adipogenesis: Understanding the Effects of Wnt Signaling on Adipogenesis and the Roles of Liver X Receptor α in Adipocyte Metabolism
2002
INTRACELLULAR LIPID-BINDING PROTEINS AND THEIR GENES
1997
Quantitation of the efflux of acylcarnitines from rat heart, brain, and liver mitochondria.
1986
Host-Gut Microbiota Metabolic Interactions
2012 StandoutScience
Perfluorooctanesulfonate and other fluorochemicals in the serum of American Red Cross adult blood donors.
2003
Peroxisome Proliferator-Activated Receptors: Nuclear Control of Metabolism*
1999 Standout
Regulation of the peroxisome proliferator-activated receptor alpha gene by glucocorticoids.
1994
Targeted Disruption of the α Isoform of the Peroxisome Proliferator-Activated Receptor Gene in Mice Results in Abolishment of the Pleiotropic Effects of Peroxisome Proliferators
1995
Molecular mediators of hepatic steatosis and liver injury
2004 Standout
Arylfluorosulfates Inactivate Intracellular Lipid Binding Protein(s) through Chemoselective SuFEx Reaction with a Binding Site Tyr Residue
2016 StandoutNobel
Sources, Fate and Transport of Perfluorocarboxylates
2005 Standout
Effect of Peroxisome Proliferator-Activated Receptor Alpha Activators on Tumor Necrosis Factor Expression in Mice during Endotoxemia
1999
Regulation of Pyruvate Dehydrogenase Kinase Expression by Peroxisome Proliferator–Activated Receptor-α Ligands, Glucocorticoids, and Insulin
2002
Evaluation of carbon flux and substrate selection through alternate pathways involving the citric acid cycle of the heart by 13C NMR spectroscopy.
1988
Intracellular localization and properties of particulate hexokinase in the Novikoff ascites tumor. Evidence for an outer mitochondrial membrane location.
1983
Works of Øystein Spydevold being referenced
Thia fatty acids, metabolism and metabolic effects
1997
Effects of perfluorooctanoic acid — a potent peroxisome proliferator in rat — on Morris hepatoma 7800C1 cells, a rat cell line
1994
Induction of peroxisomal acyl-CoA oxidase by 3-thia fatty acid, in hepatoma cells and hepatocytes in culture is modified by dexamethasone and insulin
1993
Short-term regulation of carnitine palmitoyltransferase I in cultured rat hepatocytes: spontaneous inactivation and reactivation by fatty acids
1999
Dexamethasone and Insulin Demonstrate Marked and Opposite Regulation of the Steady‐State mRNA Level of the Peroxisomal Proliferator‐Activated Receptor (PPAR) in Hepatic Cells
1994
Induction of the three peroxisomal β‐oxidation enzymes is synergistically regulated by dexamethasone and fatty acids, and counteracted by insulin in Morris 7800C1 hepatoma cells in culture
1992
The mechanism underlying the hypolipemic effect of perfluorooctanoic acid (PFOA), perfluorooctane sulphonic acid (PFOSA) and clofibric acid
1992
Retinoid X receptor (RXRα) gene expression is regulated by fatty acids and dexamethasone in hepatic cells
1997
Association of epididymal adipose tissue hexokinase with subcellular structure
1968
Effect of quinolinic acid on the distribution of hepatic metabolites
1973
Pyruvate Carboxylase and Propionyl‐CoA Carboxylase as Anaplerotic Enzymes in Skeletal Muscle Mitochondria
1980
Induction of peroxisomal β-oxidation in 7800 C1 Morris hepatoma cells in steady state by fatty acids and fatty acid analogues
1989
Replenishment and Depletion of Citric Acid Cycle Intermediates in Skeletal Muscle.
1976
Plasma lipid concentration and liver output of lipoproteins in rats fed coconut fat or sunflower oil.
1980
Activities of enzymes of lipid metabolism in Morris hepatoma 7800 C1 cells
1989
Cross-Talk between Fatty Acid and Cholesterol Metabolism Mediated by Liver X Receptor-α
2000
Decreased hexokinase activity of the rat epididymal fat pad caused by high level of free fatty acids a possible factor in the mechanism of dietary adaptation
1970